Hypertriglyceridaemia-induced acute pancreatitis due to patient non-compliance

Journal of Clinical Pharmacy and Therapeutics

Volumn 34, Issue 3, 2009, Pages 363-367

  Love, B L ^a,b   Kehr, H ^a   Olin, J L ^a  

^a WINGATE UNIVERSITY   (United States)

^b NONE   (United States)

Author keywords

Chylomicronaemia; Hyperlipidaemia; Hypertriglyceridaemia; Pancreatitis; Patient non adherence

Indexed keywords

AMYLASE; ENOXAPARIN; GEMFIBROZIL; INSULIN; MESALAZINE; METOPROLOL SUCCINATE; NARCOTIC ANALGESIC AGENT; PIPERACILLIN PLUS TAZOBACTAM; TRIACYLGLYCEROL; TRIACYLGLYCEROL LIPASE;

ABDOMINAL RADIOGRAPHY; ACUTE PANCREATITIS; ADULT; AMYLASE BLOOD LEVEL; ANTIBIOTIC THERAPY; ARTICLE; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CROHN DISEASE; DEEP VEIN THROMBOSIS; DIARRHEA; FEMALE; FEVER; HOSPITALIZATION; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; LEUKOCYTOSIS; NAUSEA; PATIENT COMPLIANCE; TRIACYLGLYCEROL BLOOD LEVEL; TRIACYLGLYCEROL LIPASE BLOOD LEVEL; UPPER ABDOMINAL PAIN; VOMITING;

ACUTE DISEASE; ADULT; ANALGESICS, OPIOID; ANTILIPEMIC AGENTS; ENOXAPARIN; FEMALE; GEMFIBROZIL; HUMANS; HYPERTRIGLYCERIDEMIA; INSULIN; MEDICATION ADHERENCE; PANCREATITIS; RECURRENCE;

EID: 65549099251     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/j.1365-2710.2008.01002.x     Document Type: Article

References (17)

1. Gan SI, Edwards AL, Symonds CJ, Beck PL (2006) Hypertriglyceridemia- induced pancreatitis: a case-based review. World Journal of Gastroenterology, 12, 7197 7202.
2. Fortson MR, Freedman SN, Webster PD III. (1995) Clinical assessment of hyperlipidemic pancreatitis. The American Journal of Gastroenterology, 90, 2134 2139.
3. Yadav D, Pitchumoni CS (2003) Issues in hyperlipidemic pancreatitis. Journal of Clinical Gastroenterology, 36, 54 62.
4. Alagozlu H, Cindoruk M, Karakan T, Unal S (2006) Heparin and insulin in the treatment of hypertriglyceridemia-induced severe acute pancreatitis. Digestive Diseases and Sciences, 51, 931 933. (Pubitemid 44030817)
5. Jabbar MA, Zuhri-Yafi MI, Larrea J (1998) Insulin therapy for a non-diabetic patient with severe hypertriglyceridemia. Journal of the American College of Nutrition, 17, 458 461. (Pubitemid 28445336)
6. Ng D 2001) Heparin in hypertriglyceridemia: friend or foe? The Journal of Laboratory and Clinical Medicine, 138, 356 358. (Pubitemid 34010019)
7. Nasstrom B, Stegmayr B, Gupta J, Olivecrona G, Olivecrona T (2005) A single bolus of a low molecular weight heparin to patients on haemodialysis depletes lipoprotein lipase stores and retards triglyceride clearing. Nephrology, Dialysis, Transplantation, 20, 1172 1179. (Pubitemid 40862107)
8. Nasstrom B, Stegmayr B, Olivecrona G, Olivecrona T (2004) Lipoprotein lipase in hemodialysis patients: indications that low molecular weight heparin depletes functional stores, despite low plasma levels of the enzyme. BMC Nephrology, 5, 17. (Pubitemid 40117651)
9. Stenvinkel P (1995) Low molecular weight heparin - does it favourably affect lipid levels? Nephrology, Dialysis, Transplantation, 10, 16 18.
10. Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (2001) Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). The Journal of the American Medical Association, 285, 2486 2497. (Pubitemid 32433843)
11. Grundy SM, Cleeman JI, Daniels SR et al. (2005) Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Executive summary. Cardiology in Review, 13, 322 327. (Pubitemid 41579599)
12. Yuan G, Al-Shali KZ, Hegele RA (2007) Hypertriglyceridemia: its etiology, effects and treatment. Canadian Medical Association Journal, 176, 1113 1120. (Pubitemid 46649735)
13. McKenney JM, Sica D (2007) Prescription omega-3 fatty acids for the treatment of hypertriglyceridemia. American Journal of Health-System Pharmacy, 64, 595 605. (Pubitemid 46481860)
14. Stromberg A (2006) Patient-related factors of compliance in heart failure: some new insights into an old problem. European Heart Journal, 27, 379 381. (Pubitemid 43210459)
15. Cole JA, Norman H, Weatherby LB, Walker AM (2006) Drug copayment and adherence in chronic heart failure: effect on cost and outcomes. Pharmacotherapy, 26, 1157 1164. (Pubitemid 44167823)
16. Weycker D, Macarios D, Edelsberg J, Oster G (2007) Compliance with osteoporosis drug therapy and risk of fracture. Osteoporosis International, 18, 271 277. (Pubitemid 46233172)
17. Valenstein M, Copeland LA, Blow FC et al. (2002) Pharmacy data identify poorly adherent patients with schizophrenia at increased risk for admission. Medical Care, 40, 630 639.